Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Takada

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Oncology Reports|March 10, 2005
Aberrant expression of HOX genes in human invasive breast carcinomaKokonoe Makiyama, Jun-Ichi Hamada, Minoru Takada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)Shinzoh Kudoh, Koji Takeda, Kazuhiko Nakagawa, et al.
Surgical Case Reports|March 21, 2025
Successful Surgical Repair of Complete Duodenal Transection Caused by Horse Kick: A Case ReportYusuke Asai, Yusuke Tsunetoshi, Yuta Susa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Is the importance of achieving stable disease different between epidermal growth factor receptor tyrosine kinase inhibitors and cytotoxic agents in the second-line setting for advanced non-small cell lung cancer?Takayasu Kurata, Keitaro Matsuo, Minoru Takada, et al.
Lung Cancer (Amsterdam, Netherlands)|October 4, 2005
Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assayKatsuhiko Endo, Akimitsu Konishi, Hidefumi Sasaki, et al.
Japanese Journal of Clinical Oncology|April 23, 2005
A phase I/II study comparing regimen schedules of gemcitabine and docetaxel in Japanese patients with stage IIIB/IV non-small cell lung cancerKaoru Matsui, Tomonori Hirashima, Takashi Nitta, et al.
Surgical Case Reports|September 24, 2025
Sarcomatoid Carcinoma in a Resected Hepatic Metastasis of Esophageal Squamous Cell Carcinoma after ChemotherapyKotaro Kimura, Yoshihiro Kinoshita, Naoya Okada, et al.
Molecular and Clinical Oncology|April 18, 2017
Phase I study of nanoparticle albumin-bound paclitaxel, carboplatin and trastuzumab in women with human epidermal growth factor receptor 2-overexpressing breast cancerKenji Tezuka, Tsutomu Takashima, Shinichiro Kashiwagi, et al.
Springerplus|March 31, 2016
A phase II, multicenter, single-arm trial of eribulin as first-line chemotherapy for HER2-negative locally advanced or metastatic breast cancerTsutomu Takashima, Shinya Tokunaga, Seika Tei, et al.
Anticancer Research|April 7, 2019
Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Trastuzumab Followed by 5-Fluorouracil/Epirubicin/Cyclophosphamide for HER2-positive Operable Breast Cancer: A Multicenter Phase II TrialShinya Tokunaga, Tsutomu Takashima, Shinichiro Kashiwagi, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Oncology Reports|March 10, 2005
Aberrant expression of HOX genes in human invasive breast carcinomaKokonoe Makiyama, Jun-Ichi Hamada, Minoru Takada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)Shinzoh Kudoh, Koji Takeda, Kazuhiko Nakagawa, et al.
Surgical Case Reports|March 21, 2025
Successful Surgical Repair of Complete Duodenal Transection Caused by Horse Kick: A Case ReportYusuke Asai, Yusuke Tsunetoshi, Yuta Susa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Is the importance of achieving stable disease different between epidermal growth factor receptor tyrosine kinase inhibitors and cytotoxic agents in the second-line setting for advanced non-small cell lung cancer?Takayasu Kurata, Keitaro Matsuo, Minoru Takada, et al.
Lung Cancer (Amsterdam, Netherlands)|October 4, 2005
Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assayKatsuhiko Endo, Akimitsu Konishi, Hidefumi Sasaki, et al.
Japanese Journal of Clinical Oncology|April 23, 2005
A phase I/II study comparing regimen schedules of gemcitabine and docetaxel in Japanese patients with stage IIIB/IV non-small cell lung cancerKaoru Matsui, Tomonori Hirashima, Takashi Nitta, et al.
Surgical Case Reports|September 24, 2025
Sarcomatoid Carcinoma in a Resected Hepatic Metastasis of Esophageal Squamous Cell Carcinoma after ChemotherapyKotaro Kimura, Yoshihiro Kinoshita, Naoya Okada, et al.
Molecular and Clinical Oncology|April 18, 2017
Phase I study of nanoparticle albumin-bound paclitaxel, carboplatin and trastuzumab in women with human epidermal growth factor receptor 2-overexpressing breast cancerKenji Tezuka, Tsutomu Takashima, Shinichiro Kashiwagi, et al.
Springerplus|March 31, 2016
A phase II, multicenter, single-arm trial of eribulin as first-line chemotherapy for HER2-negative locally advanced or metastatic breast cancerTsutomu Takashima, Shinya Tokunaga, Seika Tei, et al.
Anticancer Research|April 7, 2019
Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Trastuzumab Followed by 5-Fluorouracil/Epirubicin/Cyclophosphamide for HER2-positive Operable Breast Cancer: A Multicenter Phase II TrialShinya Tokunaga, Tsutomu Takashima, Shinichiro Kashiwagi, et al.
Pageof 11